ALTIMMUNE, INC. (ALT) Shareholder Equity
- 2026-06-30: Common Stock, Value, IssuedUSD $19.00K; Additional Paid in CapitalUSD $1.18B; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-6.04M; Retained Earnings (Accumulated Deficit)USD $-694.87M.
- 2026-03-31: Common Stock, Value, IssuedUSD $13.00K; Additional Paid in CapitalUSD $961.24M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-5.22M; Retained Earnings (Accumulated Deficit)USD $-672.05M.
- 2025-12-31: Common Stock, Value, IssuedUSD $11.00K; Additional Paid in CapitalUSD $879.29M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-4.93M; Retained Earnings (Accumulated Deficit)USD $-649.48M.
- 2025-09-30: Common Stock, Value, IssuedUSD $10.00K; Additional Paid in CapitalUSD $812.73M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-5.02M; Retained Earnings (Accumulated Deficit)USD $-622.12M.
ALTIMMUNE, INC. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Common Stock, Value, Issued USD | Additional Paid in Capital USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD | Adjustments to Additional Paid in Capital, Warrant Issued USD | Additional Paid in Capital, Common Stock USD | Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax USD | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD | Adjustments to Additional Paid in Capital, Dividends in Excess of Retained Earnings USD | Adjustments to Additional Paid in Capital, Increase in Carrying Amount of Redeemable Preferred Stock USD | Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation USD |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $19.00K | $1.18B | $-6.04M | $-694.87M | $474.21M | 3 month · $2.79M | 3 month · $30.30M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2026-03-31 | $13.00K | $961.24M | $-5.22M | $-672.05M | $283.99M | 3 month · $3.38M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-12-31 | $11.00K | $879.29M | $-4.93M | $-649.48M | $224.89M | 12 month · $16.08M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-09-30 | $10.00K | $812.73M | $-5.02M | $-622.12M | $185.60M | 3 month · $3.55M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-06-30 | $9.00K | $769.51M | $-5.04M | $-603.11M | $161.37M | 3 month · $3.57M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-03-31 | $8.00K | $728.12M | $-5.00M | $-580.97M | $142.16M | 3 month · $4.01M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | $7.00K | $689.86M | $-4.97M | $-561.39M | $123.51M | 12 month · $14.39M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-09-30 | $7.00K | $676.42M | $-4.84M | $-538.21M | $133.38M | 3 month · $3.08M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-06-30 | $7.00K | $673.08M | $-5.19M | $-515.37M | $152.53M | 3 month · $4.31M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-03-31 | $7.00K | $668.82M | $-5.16M | $-490.73M | $172.94M | 3 month · $3.65M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | $7.00K | $665.43M | $-5.00M | $-466.33M | $194.10M | 12 month · $10.64M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-09-30 | $5.00K | $590.21M | $-5.12M | $-434.69M | $150.40M | 3 month · $2.71M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-06-30 | $5.00K | $586.91M | $-5.18M | $-414.02M | $167.71M | 3 month · $2.79M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-03-31 | $5.00K | $570.79M | $-5.10M | $-397.96M | $167.73M | 3 month · $2.67M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | $5.00K | $568.40M | $-5.23M | $-377.88M | $185.29M | 12 month · $8.10M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-09-30 | $5.00K | $566.55M | $-5.30M | $-356.22M | $205.03M | 3 month · $2.13M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-06-30 | $5.00K | $532.40M | $-5.16M | $-332.71M | $194.53M | 3 month · $2.05M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-03-31 | $4.00K | $502.50M | $-5.04M | $-312.60M | $184.87M | 3 month · $2.03M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | $4.00K | $497.34M | $-5.04M | $-293.17M | $199.13M | 12 month · $5.52M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-09-30 | $3.96K | $483.58M | $-5.04M | $-269.28M | $209.26M | 3 month · $1.50M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-06-30 | $3.96K | $482.08M | $-5.04M | $-235.77M | $241.28M | 3 month · $1.49M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-03-31 | $3.81K | $462.42M | $-5.04M | $-210.94M | $246.44M | 3 month · $1.22M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | $3.70K | $417.34M | $-5.04M | $-186.42M | $225.88M | 12 month · $2.58M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-09-30 | $3.29K | $380.54M | $-5.04M | $-175.80M | $199.71M | 3 month · $1.32M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-06-30 | $2.63K | $242.58M | $-5.03M | $-158.03M | $79.52M | 3 month · $330.51K | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-03-31 | $1.51K | $188.21M | $-5.05M | $-141.26M | $41.90M | 3 month · $214.92K | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-12-31 | $1.51K | $187.91M | $-5.02M | $-137.38M | $45.52M | 12 month · $1.26M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-09-30 | $1.50K | $187.68M | $-5.02M | $-133.28M | $49.38M | 3 month · $287.77K | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-06-30 | $1.31K | $183.60M | $-5.04M | $-122.34M | $56.23M | 3 month · $289.77K | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-03-31 | $1.31K | $183.31M | $-5.04M | $-118.95M | $59.32M | 3 month · $407.71K | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-12-31 | $876.00 | $170.21M | $-5.04M | $-116.86M | $48.31M | 12 month · $762.16K | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-09-30 | $173.00 | $137.07M | $-5.04M | $-92.35M | $39.68M | 9 month · $722.45K | (m) | (m) | (m) | (m) | (m) | (m) | 9 month · $18.35K |
| 2018-06-30 | $3.74K | $130.84M | $-5.04M | $-90.00M | $35.81M | 6 month · $623.56K | (m) | (m) | (m) | (m) | (m) | (m) | 6 month · $18.35K |
| 2018-03-31 | $2.23K | $125.36M | $-3.96M | $-80.86M | $40.54M | 3 month · $363.79K | (m) | (m) | (m) | (m) | (m) | (m) | 3 month · $18.35K |
| 2017-12-31 | $61.00 | $121.66M | $-4.58M | $-77.68M | $39.40M | 12 month · $1.21M | 12 month · $548.96K | (m) | (m) | (m) | (m) | 12 month · $-1.51M | (m) |
| 2017-09-30 | $1.56K | $122.39M | $-4.71M | $-68.85M | $48.83M | 9 month · $905.23K | 9 month · $548.96K | (m) | (m) | (m) | (m) | 9 month · $-3.22M | (m) |
| 2017-06-30 | $1.54K | $120.66M | $-5.74M | $-38.95M | $75.98M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-03-31 | $6.88K | $50.11M | $0.00 | $-32.07M | $29.10M | 3 month · $197.13K | 3 month · $548.96K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-12-31 | $692.00 | $71.03M | $-7.57M | $-31.26M | $32.21M | 12 month · $794.58K | (m) | (m) | (m) | (m) | 12 month · $197.08M | (m) | (m) |
| 2016-09-30 | $6.64K | $244.04M | $12.35K | $-107.67M | $136.38M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-06-30 | $6.48K | $241.15M | (m) | $-216.91M | $24.25M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-03-31 | $6.44K | $240.57M | (m) | $-224.95M | $15.63M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-12-31 | $6.44K | $240.37M | $0.00 | $-223.72M | $43.13M | 12 month · $613.02K | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-09-30 | $6.44K | (m) | (m) | $-222.49M | $17.67M | (m) | (m) | $240.15M | (m) | (m) | (m) | (m) | (m) |
| 2015-06-30 | $6.39K | (m) | (m) | $-221.16M | $18.34M | (m) | (m) | $239.49M | (m) | (m) | (m) | (m) | (m) |
| 2015-03-31 | $6.37K | (m) | (m) | $-218.82M | $20.02M | (m) | (m) | $239.06M | $-227.78K | (m) | (m) | (m) | (m) |
| 2014-12-31 | $6.36K | $238.78M | $-229.53K | $-220.28M | $18.27M | 12 month · $1.65M | (m) | $238.78M | $-229.53K | (m) | (m) | (m) | (m) |
| 2014-09-30 | $6.22K | (m) | (m) | $-217.65M | $18.11M | (m) | (m) | $235.98M | $-225.87K | (m) | (m) | (m) | (m) |
| 2014-06-30 | $5.55K | (m) | (m) | $-213.03M | $10.86M | (m) | (m) | $224.10M | $-220.00K | (m) | (m) | (m) | (m) |
| 2014-03-31 | $5.38K | (m) | (m) | $-212.59M | $8.33M | (m) | (m) | $221.13M | $-219.37K | (m) | (m) | (m) | (m) |
| 2013-12-31 | $5.23K | (m) | (m) | $-210.33M | $7.34M | 12 month · $1.35M | (m) | $217.88M | $-218.71K | (m) | (m) | (m) | (m) |
| 2013-09-30 | $5.23K | (m) | (m) | $-205.90M | $11.35M | (m) | (m) | $217.47M | $-220.11K | (m) | (m) | (m) | (m) |
| 2013-06-30 | $5.12K | (m) | (m) | $-201.96M | $13.22M | (m) | (m) | $215.39M | $-220.27K | (m) | (m) | (m) | (m) |
| 2013-03-31 | $4.84K | (m) | (m) | $-200.72M | $9.94M | (m) | (m) | $210.88M | $-219.01K | (m) | (m) | (m) | (m) |
| 2012-12-31 | $4.83K | (m) | (m) | $-198.61M | $11.67M | 12 month · $1.80M | (m) | $210.50M | $-217.33K | (m) | (m) | (m) | (m) |
| 2012-09-30 | $4.83K | (m) | (m) | $-197.34M | $12.55M | (m) | (m) | $210.10M | $-215.98K | (m) | (m) | (m) | (m) |
| 2012-06-30 | $4.83K | (m) | (m) | $-197.13M | $13.55M | (m) | (m) | $209.66M | $1.00M | (m) | (m) | (m) | (m) |
| 2012-03-31 | $4.83K | (m) | (m) | $-196.37M | $13.77M | (m) | (m) | $209.11M | $1.02M | (m) | (m) | (m) | (m) |
| 2011-12-31 | $4.82K | (m) | (m) | $-193.69M | $15.85M | 12 month · $2.25M | (m) | $208.53M | $1.01M | (m) | (m) | (m) | (m) |
| 2011-09-30 | $4.82K | (m) | (m) | $-194.44M | $14.54M | (m) | (m) | $207.81M | $1.16M | (m) | (m) | (m) | (m) |
| 2011-06-30 | $4.82K | (m) | (m) | $-194.41M | $14.07M | (m) | (m) | $207.23M | $1.24M | (m) | (m) | (m) | (m) |
| 2010-12-31 | $4.62K | (m) | (m) | $-189.89M | $12.21M | 12 month · $2.29M | (m) | $200.85M | $1.25M | (m) | (m) | (m) | (m) |
| 2010-11-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 1 month · $400.00K | (m) | (m) | (m) |
| 2010-07-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 1 month · $145.00K | (m) | (m) | (m) |
| 2010-04-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 1 month · $140.00K | (m) | (m) | (m) |
| 2009-12-31 | (m) | (m) | (m) | (m) | $3.15M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B |